Bi-monthly journal on neurovirology from Springer

Journal enhances neuroscience portfolio by covering new area

Starting in January 2011, Springer will publish the Journal of NeuroVirology (JNV), a bi-monthly publication closely affiliated with the International Society for NeuroVirology. Previously published by Taylor & Francis/Informa, the five-year contract with Springer runs to 2015.

The Journal of NeuroVirology publishes high-quality basic science and clinical studies on the molecular biology and pathogenesis of viral infections of the nervous system, and reports on the development of novel therapeutic strategies using neurotropic viral vectors. The journal also focuses on articles covering non-viral infections that affect the central nervous system. Original research articles, reviews, case reports and coverage of scientific meetings are included. The editor-in-chief is Professor Kamel Khalili, Chair of the Department of Neuroscience at Temple University School of Medicine in Philadelphia, USA.

Ann Avouris, Senior Editor of Neuroscience at Springer, said, "The journal brings additional content for Springer's neuroscience portfolio in an area that is currently not covered. The subject is growing in interest, with new studies being published on neuroAIDS, viruses and neurodegeneration, and transmissible encephalopathies. Springer will be able to help grow the society, and support them in accomplishing their mission."

Professor Khalili said, "Since its inception in 1995, JNV has provided a unique platform for cross communication between basic scientists and clinican researchers studying viral disorders of the nervous system. We're excited about our new partnership and will work closely with Springer to continue advancing the field of neurovirology and infections of the nervous system as a whole."

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
UCL scientists receive £78 million funding boost to develop treatment for motor neurone disease